APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Blood Plasma Products and Derivatives

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Animal Blood Plasma Products and Derivatives Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchAnimal Blood Plasma Products and Derivatives Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Blood Plasma Products and Derivatives Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Animal Blood Plasma Products and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Blood Plasma Products and Derivatives Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Blood Plasma Products and Derivatives Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Animal Blood Plasma Products and Derivatives market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Animal Blood Plasma Products and Derivatives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Animal Blood Plasma Products and Derivatives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Animal Blood Plasma Products and Derivatives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Animal Blood Plasma Products and Derivatives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Animal Blood Plasma Products and Derivatives include Thermo Fisher Scientific, Sigma-Aldrich, Rocky Mountain Biologicals, Proliant, LAMPIRE Biological Laboratories, Lake Immunogenics, Kraeber & Co. GmbH, Bovogen Biologicals and Auckland BioSciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Animal Blood Plasma Products and Derivatives, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Animal Blood Plasma Products and Derivatives, also provides the sales of main regions and countries. Of the upcoming market potential for Animal Blood Plasma Products and Derivatives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Animal Blood Plasma Products and Derivatives sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Animal Blood Plasma Products and Derivatives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Animal Blood Plasma Products and Derivatives sales, projected growth trends, production technology, application and end-user industry.

Animal Blood Plasma Products and Derivatives Segment by Company

Thermo Fisher Scientific

Sigma-Aldrich

Rocky Mountain Biologicals

Proliant

LAMPIRE Biological Laboratories

Lake Immunogenics

Kraeber & Co. GmbH

Bovogen Biologicals

Auckland BioSciences

ANZCO Foods

Animal Blood Plasma Products and Derivatives Segment by Type

Serum Albumin

Fibrinogen

Fetal Bovine Serum

Immunoglobulin

Animal Blood Plasma Products and Derivatives Segment by Application

Pharmaceutical Industry

Diagnostic Industry

Sports Nutrition

Nutrition Supplements

Cell Culture Media

Food Industry

Cosmetic Industry

Pet Food Industry

Animal Blood Plasma Products and Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Blood Plasma Products and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Blood Plasma Products and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Blood Plasma Products and Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Animal Blood Plasma Products and Derivatives in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Animal Blood Plasma Products and Derivatives manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Blood Plasma Products and Derivatives sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Serum Albumin Major Manufacturers Table 3. Fibrinogen Major Manufacturers Table 4. Fetal Bovine Serum Major Manufacturers Table 5. Immunoglobulin Major Manufacturers Table 6. Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Industry Major Manufacturers Table 8. Diagnostic Industry Major Manufacturers Table 9. Sports Nutrition Major Manufacturers Table 10. Nutrition Supplements Major Manufacturers Table 11. Cell Culture Media Major Manufacturers Table 12. Food Industry Major Manufacturers Table 13. Cosmetic Industry Major Manufacturers Table 14. Pet Food Industry Major Manufacturers Table 15. Animal Blood Plasma Products and Derivatives Industry Trends Table 16. Animal Blood Plasma Products and Derivatives Industry Drivers Table 17. Animal Blood Plasma Products and Derivatives Industry Opportunities and Challenges Table 18. Animal Blood Plasma Products and Derivatives Industry Restraints Table 19. Global Animal Blood Plasma Products and Derivatives Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Animal Blood Plasma Products and Derivatives Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Animal Blood Plasma Products and Derivatives Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region (2021-2026) Table 23. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region (2027-2032) Table 24. Global Animal Blood Plasma Products and Derivatives Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 25. Global Animal Blood Plasma Products and Derivatives Sales by Region (2021-2026) & (tons) Table 26. Global Animal Blood Plasma Products and Derivatives Sales by Region (2027-2032) & (tons) Table 27. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2021-2026) Table 28. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2027-2032) Table 29. Global Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Animal Blood Plasma Products and Derivatives Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Manufacturers (2021-2026) Table 33. Global Animal Blood Plasma Products and Derivatives Sales Price (US$/kg) of Manufacturers (2021-2026) Table 34. Global Animal Blood Plasma Products and Derivatives Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Animal Blood Plasma Products and Derivatives Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Animal Blood Plasma Products and Derivatives Manufacturers, Product Type & Application Table 37. Global Animal Blood Plasma Products and Derivatives Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Animal Blood Plasma Products and Derivatives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Animal Blood Plasma Products and Derivatives Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 42. Global Animal Blood Plasma Products and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 43. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2021-2026) Table 44. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2027-2032) Table 45. Global Animal Blood Plasma Products and Derivatives Sales by Type 2021 VS 2025 VS 2032 (tons) Table 46. Global Animal Blood Plasma Products and Derivatives Sales by Type (2021-2026) & (tons) Table 47. Global Animal Blood Plasma Products and Derivatives Sales by Type (2027-2032) & (tons) Table 48. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2021-2026) Table 49. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2027-2032) Table 50. Global Animal Blood Plasma Products and Derivatives Price by Type (2021-2026) & (US$/kg) Table 51. Global Animal Blood Plasma Products and Derivatives Price by Type (2027-2032) & (US$/kg) Table 52. Global Animal Blood Plasma Products and Derivatives Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Animal Blood Plasma Products and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2021-2026) Table 56. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2027-2032) Table 57. Global Animal Blood Plasma Products and Derivatives Sales by Application 2021 VS 2025 VS 2032 (tons) Table 58. Global Animal Blood Plasma Products and Derivatives Sales by Application (2021-2026) & (tons) Table 59. Global Animal Blood Plasma Products and Derivatives Sales by Application (2027-2032) & (tons) Table 60. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2021-2026) Table 61. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2027-2032) Table 62. Global Animal Blood Plasma Products and Derivatives Price by Application (2021-2026) & (US$/kg) Table 63. Global Animal Blood Plasma Products and Derivatives Price by Application (2027-2032) & (US$/kg) Table 64. Thermo Fisher Scientific Company Information Table 65. Thermo Fisher Scientific Business Overview Table 66. Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 67. Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product Portfolio Table 68. Thermo Fisher Scientific Recent Development Table 69. Sigma-Aldrich Company Information Table 70. Sigma-Aldrich Business Overview Table 71. Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 72. Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product Portfolio Table 73. Sigma-Aldrich Recent Development Table 74. Rocky Mountain Biologicals Company Information Table 75. Rocky Mountain Biologicals Business Overview Table 76. Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 77. Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio Table 78. Rocky Mountain Biologicals Recent Development Table 79. Proliant Company Information Table 80. Proliant Business Overview Table 81. Proliant Animal Blood Plasma Products and Derivatives Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 82. Proliant Animal Blood Plasma Products and Derivatives Product Portfolio Table 83. Proliant Recent Development Table 84. LAMPIRE Biological Laboratories Company Information Table 85. LAMPIRE Biological Laboratories Business Overview Table 86. LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 87. LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product Portfolio Table 88. LAMPIRE Biological Laboratories Recent Development Table 89. Lake Immunogenics Company Information Table 90. Lake Immunogenics Business Overview Table 91. Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 92. Lake Immunogenics Animal Blood Plasma Products and Derivatives Product Portfolio Table 93. Lake Immunogenics Recent Development Table 94. Kraeber & Co. GmbH Company Information Table 95. Kraeber & Co. GmbH Business Overview Table 96. Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 97. Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product Portfolio Table 98. Kraeber & Co. GmbH Recent Development Table 99. Bovogen Biologicals Company Information Table 100. Bovogen Biologicals Business Overview Table 101. Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 102. Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio Table 103. Bovogen Biologicals Recent Development Table 104. Auckland BioSciences Company Information Table 105. Auckland BioSciences Business Overview Table 106. Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 107. Auckland BioSciences Animal Blood Plasma Products and Derivatives Product Portfolio Table 108. Auckland BioSciences Recent Development Table 109. ANZCO Foods Company Information Table 110. ANZCO Foods Business Overview Table 111. ANZCO Foods Animal Blood Plasma Products and Derivatives Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 112. ANZCO Foods Animal Blood Plasma Products and Derivatives Product Portfolio Table 113. ANZCO Foods Recent Development Table 114. North America Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 115. North America Animal Blood Plasma Products and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 116. North America Animal Blood Plasma Products and Derivatives Sales by Type (2021-2026) & (tons) Table 117. North America Animal Blood Plasma Products and Derivatives Sales by Type (2027-2032) & (tons) Table 118. North America Animal Blood Plasma Products and Derivatives Sales Price by Type (2021-2026) & (US$/kg) Table 119. North America Animal Blood Plasma Products and Derivatives Sales Price by Type (2027-2032) & (US$/kg) Table 120. North America Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 121. North America Animal Blood Plasma Products and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 122. North America Animal Blood Plasma Products and Derivatives Sales by Application (2021-2026) & (tons) Table 123. North America Animal Blood Plasma Products and Derivatives Sales by Application (2027-2032) & (tons) Table 124. North America Animal Blood Plasma Products and Derivatives Sales Price by Application (2021-2026) & (US$/kg) Table 125. North America Animal Blood Plasma Products and Derivatives Sales Price by Application (2027-2032) & (US$/kg) Table 126. North America Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. North America Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. North America Animal Blood Plasma Products and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 130. North America Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026) & (tons) Table 131. North America Animal Blood Plasma Products and Derivatives Sales by Country (2027-2032) & (tons) Table 132. North America Animal Blood Plasma Products and Derivatives Sales Price by Country (2021-2026) & (US$/kg) Table 133. North America Animal Blood Plasma Products and Derivatives Sales Price by Country (2027-2032) & (US$/kg) Table 134. United States Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 135. Canada Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 136. Mexico Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 137. Europe Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Animal Blood Plasma Products and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Animal Blood Plasma Products and Derivatives Sales by Type (2021-2026) & (tons) Table 140. Europe Animal Blood Plasma Products and Derivatives Sales by Type (2027-2032) & (tons) Table 141. Europe Animal Blood Plasma Products and Derivatives Sales Price by Type (2021-2026) & (US$/kg) Table 142. Europe Animal Blood Plasma Products and Derivatives Sales Price by Type (2027-2032) & (US$/kg) Table 143. Europe Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 144. Europe Animal Blood Plasma Products and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 145. Europe Animal Blood Plasma Products and Derivatives Sales by Application (2021-2026) & (tons) Table 146. Europe Animal Blood Plasma Products and Derivatives Sales by Application (2027-2032) & (tons) Table 147. Europe Animal Blood Plasma Products and Derivatives Sales Price by Application (2021-2026) & (US$/kg) Table 148. Europe Animal Blood Plasma Products and Derivatives Sales Price by Application (2027-2032) & (US$/kg) Table 149. Europe Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Europe Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Europe Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Europe Animal Blood Plasma Products and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 153. Europe Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026) & (tons) Table 154. Europe Animal Blood Plasma Products and Derivatives Sales by Country (2027-2032) & (tons) Table 155. Europe Animal Blood Plasma Products and Derivatives Sales Price by Country (2021-2026) & (US$/kg) Table 156. Europe Animal Blood Plasma Products and Derivatives Sales Price by Country (2027-2032) & (US$/kg) Table 157. Germany Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 158. France Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 159. U.K. Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 160. Italy Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 161. Russia Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 162. Spain Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 163. Netherlands Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 164. Switzerland Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 165. Sweden Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 166. Poland Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 167. China Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 168. China Animal Blood Plasma Products and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 169. China Animal Blood Plasma Products and Derivatives Sales by Type (2021-2026) & (tons) Table 170. China Animal Blood Plasma Products and Derivatives Sales by Type (2027-2032) & (tons) Table 171. China Animal Blood Plasma Products and Derivatives Sales Price by Type (2021-2026) & (US$/kg) Table 172. China Animal Blood Plasma Products and Derivatives Sales Price by Type (2027-2032) & (US$/kg) Table 173. China Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 174. China Animal Blood Plasma Products and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 175. China Animal Blood Plasma Products and Derivatives Sales by Application (2021-2026) & (tons) Table 176. China Animal Blood Plasma Products and Derivatives Sales by Application (2027-2032) & (tons) Table 177. China Animal Blood Plasma Products and Derivatives Sales Price by Application (2021-2026) & (US$/kg) Table 178. China Animal Blood Plasma Products and Derivatives Sales Price by Application (2027-2032) & (US$/kg) Table 179. Asia Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 180. Asia Animal Blood Plasma Products and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 181. Asia Animal Blood Plasma Products and Derivatives Sales by Type (2021-2026) & (tons) Table 182. Asia Animal Blood Plasma Products and Derivatives Sales by Type (2027-2032) & (tons) Table 183. Asia Animal Blood Plasma Products and Derivatives Sales Price by Type (2021-2026) & (US$/kg) Table 184. Asia Animal Blood Plasma Products and Derivatives Sales Price by Type (2027-2032) & (US$/kg) Table 185. Asia Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 186. Asia Animal Blood Plasma Products and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 187. Asia Animal Blood Plasma Products and Derivatives Sales by Application (2021-2026) & (tons) Table 188. Asia Animal Blood Plasma Products and Derivatives Sales by Application (2027-2032) & (tons) Table 189. Asia Animal Blood Plasma Products and Derivatives Sales Price by Application (2021-2026) & (US$/kg) Table 190. Asia Animal Blood Plasma Products and Derivatives Sales Price by Application (2027-2032) & (US$/kg) Table 191. Asia Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. Asia Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. Asia Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. Asia Animal Blood Plasma Products and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 195. Asia Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026) & (tons) Table 196. Asia Animal Blood Plasma Products and Derivatives Sales by Country (2027-2032) & (tons) Table 197. Asia Animal Blood Plasma Products and Derivatives Sales Price by Country (2021-2026) & (US$/kg) Table 198. Asia Animal Blood Plasma Products and Derivatives Sales Price by Country (2027-2032) & (US$/kg) Table 199. Japan Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 200. South Korea Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 201. India Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 202. Australia Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 203. Taiwan Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 204. Southeast Asia Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 205. SAMEA Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 206. SAMEA Animal Blood Plasma Products and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 207. SAMEA Animal Blood Plasma Products and Derivatives Sales by Type (2021-2026) & (tons) Table 208. SAMEA Animal Blood Plasma Products and Derivatives Sales by Type (2027-2032) & (tons) Table 209. SAMEA Animal Blood Plasma Products and Derivatives Sales Price by Type (2021-2026) & (US$/kg) Table 210. SAMEA Animal Blood Plasma Products and Derivatives Sales Price by Type (2027-2032) & (US$/kg) Table 211. SAMEA Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 212. SAMEA Animal Blood Plasma Products and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 213. SAMEA Animal Blood Plasma Products and Derivatives Sales by Application (2021-2026) & (tons) Table 214. SAMEA Animal Blood Plasma Products and Derivatives Sales by Application (2027-2032) & (tons) Table 215. SAMEA Animal Blood Plasma Products and Derivatives Sales Price by Application (2021-2026) & (US$/kg) Table 216. SAMEA Animal Blood Plasma Products and Derivatives Sales Price by Application (2027-2032) & (US$/kg) Table 217. SAMEA Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 218. SAMEA Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 219. SAMEA Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 220. SAMEA Animal Blood Plasma Products and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 221. SAMEA Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026) & (tons) Table 222. SAMEA Animal Blood Plasma Products and Derivatives Sales by Country (2027-2032) & (tons) Table 223. SAMEA Animal Blood Plasma Products and Derivatives Sales Price by Country (2021-2026) & (US$/kg) Table 224. SAMEA Animal Blood Plasma Products and Derivatives Sales Price by Country (2027-2032) & (US$/kg) Table 225. Brazil Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 226. Argentina Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 227. Chile Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 228. Colombia Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 229. Peru Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 230. Saudi Arabia Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 231. Israel Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 232. UAE Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 233. Turkey Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 234. Iran Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 235. Egypt Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Table 236. Key Raw Materials Table 237. Raw Materials Key Suppliers Table 238. Animal Blood Plasma Products and Derivatives Distributors List Table 239. Animal Blood Plasma Products and Derivatives Customers List Table 240. Research Programs/Design for This Report Table 241. Authors List of This Report Table 242. Secondary Sources Table 243. Primary Sources List of Figures Figure 1. Animal Blood Plasma Products and Derivatives Image Figure 2. Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Blood Plasma Products and Derivatives Market Size Share 2021 VS 2025 VS 2032 Figure 4. Serum Albumin Image Figure 5. Fibrinogen Image Figure 6. Fetal Bovine Serum Image Figure 7. Immunoglobulin Image Figure 8. Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Animal Blood Plasma Products and Derivatives Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Industry Image Figure 11. Diagnostic Industry Image Figure 12. Sports Nutrition Image Figure 13. Nutrition Supplements Image Figure 14. Cell Culture Media Image Figure 15. Food Industry Image Figure 16. Cosmetic Industry Image Figure 17. Pet Food Industry Image Figure 18. Global Animal Blood Plasma Products and Derivatives Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Figure 20. Global Animal Blood Plasma Products and Derivatives Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region (2021-2032) Figure 23. Global Animal Blood Plasma Products and Derivatives Sales (2021-2032) & (tons) Figure 24. Global Animal Blood Plasma Products and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 25. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico Animal Blood Plasma Products and Derivatives Sales YoY (2021-2032) & (tons) Figure 27. Europe Animal Blood Plasma Products and Derivatives Sales YoY (2021-2032) & (tons) Figure 28. China Animal Blood Plasma Products and Derivatives Sales YoY (2021-2032) & (tons) Figure 29. Asia (Excluding China) Animal Blood Plasma Products and Derivatives Sales YoY (2021-2032) & (tons) Figure 30. South America, Middle East and Africa Animal Blood Plasma Products and Derivatives Sales YoY (2021-2032) & (tons) Figure 31. Global Animal Blood Plasma Products and Derivatives Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global Animal Blood Plasma Products and Derivatives Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global Animal Blood Plasma Products and Derivatives Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2021-2032) Figure 37. Global Animal Blood Plasma Products and Derivatives Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 38. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2021-2032) Figure 40. Global Animal Blood Plasma Products and Derivatives Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2021-2032) Figure 43. Global Animal Blood Plasma Products and Derivatives Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 44. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2021-2032) Figure 46. North America Animal Blood Plasma Products and Derivatives Revenue Share by Type (2021-2032) Figure 47. North America Animal Blood Plasma Products and Derivatives Sales Share by Type (2021-2032) Figure 48. North America Animal Blood Plasma Products and Derivatives Revenue Share by Application (2021-2032) Figure 49. North America Animal Blood Plasma Products and Derivatives Sales Share by Application (2021-2032) Figure 50. North America Animal Blood Plasma Products and Derivatives Revenue Share by Country (2021-2032) Figure 51. North America Animal Blood Plasma Products and Derivatives Sales Share by Country (2021-2032) Figure 52. Europe Animal Blood Plasma Products and Derivatives Revenue Share by Type (2021-2032) Figure 53. Europe Animal Blood Plasma Products and Derivatives Sales Share by Type (2021-2032) Figure 54. Europe Animal Blood Plasma Products and Derivatives Revenue Share by Application (2021-2032) Figure 55. Europe Animal Blood Plasma Products and Derivatives Sales Share by Application (2021-2032) Figure 56. Europe Animal Blood Plasma Products and Derivatives Revenue Share by Country (2021-2032) Figure 57. Europe Animal Blood Plasma Products and Derivatives Sales Share by Country (2021-2032) Figure 58. China Animal Blood Plasma Products and Derivatives Revenue Share by Type (2021-2032) Figure 59. China Animal Blood Plasma Products and Derivatives Sales Share by Type (2021-2032) Figure 60. China Animal Blood Plasma Products and Derivatives Revenue Share by Application (2021-2032) Figure 61. China Animal Blood Plasma Products and Derivatives Sales Share by Application (2021-2032) Figure 62. Asia Animal Blood Plasma Products and Derivatives Revenue Share by Type (2021-2032) Figure 63. Asia Animal Blood Plasma Products and Derivatives Sales Share by Type (2021-2032) Figure 64. Asia Animal Blood Plasma Products and Derivatives Revenue Share by Application (2021-2032) Figure 65. Asia Animal Blood Plasma Products and Derivatives Sales Share by Application (2021-2032) Figure 66. Asia Animal Blood Plasma Products and Derivatives Revenue Share by Country (2021-2032) Figure 67. Asia Animal Blood Plasma Products and Derivatives Sales Share by Country (2021-2032) Figure 68. SAMEA Animal Blood Plasma Products and Derivatives Revenue Share by Type (2021-2032) Figure 69. SAMEA Animal Blood Plasma Products and Derivatives Sales Share by Type (2021-2032) Figure 70. SAMEA Animal Blood Plasma Products and Derivatives Revenue Share by Application (2021-2032) Figure 71. SAMEA Animal Blood Plasma Products and Derivatives Sales Share by Application (2021-2032) Figure 72. SAMEA Animal Blood Plasma Products and Derivatives Revenue Share by Country (2021-2032) Figure 73. SAMEA Animal Blood Plasma Products and Derivatives Sales Share by Country (2021-2032) Figure 74. Animal Blood Plasma Products and Derivatives Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Animal Blood Plasma Products and Derivatives Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Serum Albumin
  • Fibrinogen
  • Fetal Bovine Serum
  • Immunoglobulin
Applications
  • Pharmaceutical Industry
  • Diagnostic Industry
  • Sports Nutrition
  • Nutrition Supplements
  • Cell Culture Media
  • Food Industry
  • Cosmetic Industry
  • Pet Food Industry
Companies covered
  • Thermo Fisher Scientific
  • Sigma-Aldrich
  • Rocky Mountain Biologicals
  • Proliant
  • LAMPIRE Biological Laboratories
  • Lake Immunogenics
  • Kraeber & Co. GmbH
  • Bovogen Biologicals
  • Auckland BioSciences
  • ANZCO Foods

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Animal Blood Plasma Products and Derivatives Market by Type
  3. 1.2.1 Global Animal Blood Plasma Products and Derivatives Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Serum Albumin
  5. 1.2.3 Fibrinogen
  6. 1.2.4 Fetal Bovine Serum
  7. 1.2.5 Immunoglobulin
  8. 1.3 Animal Blood Plasma Products and Derivatives Market by Application
  9. 1.3.1 Global Animal Blood Plasma Products and Derivatives Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Industry
  11. 1.3.3 Diagnostic Industry
  12. 1.3.4 Sports Nutrition
  13. 1.3.5 Nutrition Supplements
  14. 1.3.6 Cell Culture Media
  15. 1.3.7 Food Industry
  16. 1.3.8 Cosmetic Industry
  17. 1.3.9 Pet Food Industry
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Animal Blood Plasma Products and Derivatives Market Dynamics
  1. 2.1 Animal Blood Plasma Products and Derivatives Industry Trends
  2. 2.2 Animal Blood Plasma Products and Derivatives Industry Drivers
  3. 2.3 Animal Blood Plasma Products and Derivatives Industry Opportunities and Challenges
  4. 2.4 Animal Blood Plasma Products and Derivatives Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Animal Blood Plasma Products and Derivatives Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Animal Blood Plasma Products and Derivatives Revenue by Region
  3. 3.2.1 Global Animal Blood Plasma Products and Derivatives Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Animal Blood Plasma Products and Derivatives Revenue by Region (2021-2026)
  5. 3.2.3 Global Animal Blood Plasma Products and Derivatives Revenue by Region (2027-2032)
  6. 3.2.4 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Animal Blood Plasma Products and Derivatives Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Animal Blood Plasma Products and Derivatives Sales by Region
  9. 3.4.1 Global Animal Blood Plasma Products and Derivatives Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Animal Blood Plasma Products and Derivatives Sales by Region (2021-2026)
  11. 3.4.3 Global Animal Blood Plasma Products and Derivatives Sales by Region (2027-2032)
  12. 3.4.4 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Animal Blood Plasma Products and Derivatives Revenue by Manufacturers
  2. 4.1.1 Global Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Animal Blood Plasma Products and Derivatives Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Animal Blood Plasma Products and Derivatives Sales by Manufacturers
  6. 4.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Animal Blood Plasma Products and Derivatives Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Animal Blood Plasma Products and Derivatives Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Animal Blood Plasma Products and Derivatives Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Animal Blood Plasma Products and Derivatives Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Animal Blood Plasma Products and Derivatives Manufacturers, Product Type & Application
  13. 4.7 Global Animal Blood Plasma Products and Derivatives Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Animal Blood Plasma Products and Derivatives Market CR5 and HHI
  16. 4.8.2 2025 Animal Blood Plasma Products and Derivatives Tier 1, Tier 2, and Tier 3
5 Animal Blood Plasma Products and Derivatives Market by Type
  1. 5.1 Global Animal Blood Plasma Products and Derivatives Revenue by Type
  2. 5.1.1 Global Animal Blood Plasma Products and Derivatives Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Animal Blood Plasma Products and Derivatives Sales by Type
  6. 5.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Animal Blood Plasma Products and Derivatives Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2021-2032)
  9. 5.3 Global Animal Blood Plasma Products and Derivatives Price by Type
6 Animal Blood Plasma Products and Derivatives Market by Application
  1. 6.1 Global Animal Blood Plasma Products and Derivatives Revenue by Application
  2. 6.1.1 Global Animal Blood Plasma Products and Derivatives Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Animal Blood Plasma Products and Derivatives Sales by Application
  6. 6.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Animal Blood Plasma Products and Derivatives Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2021-2032)
  9. 6.3 Global Animal Blood Plasma Products and Derivatives Price by Application
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Sigma-Aldrich
  8. 7.2.1 Sigma-Aldrich Company Information
  9. 7.2.2 Sigma-Aldrich Business Overview
  10. 7.2.3 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product Portfolio
  12. 7.2.5 Sigma-Aldrich Recent Developments
  13. 7.3 Rocky Mountain Biologicals
  14. 7.3.1 Rocky Mountain Biologicals Company Information
  15. 7.3.2 Rocky Mountain Biologicals Business Overview
  16. 7.3.3 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio
  18. 7.3.5 Rocky Mountain Biologicals Recent Developments
  19. 7.4 Proliant
  20. 7.4.1 Proliant Company Information
  21. 7.4.2 Proliant Business Overview
  22. 7.4.3 Proliant Animal Blood Plasma Products and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Proliant Animal Blood Plasma Products and Derivatives Product Portfolio
  24. 7.4.5 Proliant Recent Developments
  25. 7.5 LAMPIRE Biological Laboratories
  26. 7.5.1 LAMPIRE Biological Laboratories Company Information
  27. 7.5.2 LAMPIRE Biological Laboratories Business Overview
  28. 7.5.3 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product Portfolio
  30. 7.5.5 LAMPIRE Biological Laboratories Recent Developments
  31. 7.6 Lake Immunogenics
  32. 7.6.1 Lake Immunogenics Company Information
  33. 7.6.2 Lake Immunogenics Business Overview
  34. 7.6.3 Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lake Immunogenics Animal Blood Plasma Products and Derivatives Product Portfolio
  36. 7.6.5 Lake Immunogenics Recent Developments
  37. 7.7 Kraeber & Co. GmbH
  38. 7.7.1 Kraeber & Co. GmbH Company Information
  39. 7.7.2 Kraeber & Co. GmbH Business Overview
  40. 7.7.3 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product Portfolio
  42. 7.7.5 Kraeber & Co. GmbH Recent Developments
  43. 7.8 Bovogen Biologicals
  44. 7.8.1 Bovogen Biologicals Company Information
  45. 7.8.2 Bovogen Biologicals Business Overview
  46. 7.8.3 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio
  48. 7.8.5 Bovogen Biologicals Recent Developments
  49. 7.9 Auckland BioSciences
  50. 7.9.1 Auckland BioSciences Company Information
  51. 7.9.2 Auckland BioSciences Business Overview
  52. 7.9.3 Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Auckland BioSciences Animal Blood Plasma Products and Derivatives Product Portfolio
  54. 7.9.5 Auckland BioSciences Recent Developments
  55. 7.10 ANZCO Foods
  56. 7.10.1 ANZCO Foods Company Information
  57. 7.10.2 ANZCO Foods Business Overview
  58. 7.10.3 ANZCO Foods Animal Blood Plasma Products and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 ANZCO Foods Animal Blood Plasma Products and Derivatives Product Portfolio
  60. 7.10.5 ANZCO Foods Recent Developments
8 North America
  1. 8.1 North America Animal Blood Plasma Products and Derivatives Market Size by Type
  2. 8.1.1 North America Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2032)
  3. 8.1.2 North America Animal Blood Plasma Products and Derivatives Sales by Type (2021-2032)
  4. 8.1.3 North America Animal Blood Plasma Products and Derivatives Price by Type (2021-2032)
  5. 8.2 North America Animal Blood Plasma Products and Derivatives Market Size by Application
  6. 8.2.1 North America Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2032)
  7. 8.2.2 North America Animal Blood Plasma Products and Derivatives Sales by Application (2021-2032)
  8. 8.2.3 North America Animal Blood Plasma Products and Derivatives Price by Application (2021-2032)
  9. 8.3 North America Animal Blood Plasma Products and Derivatives Market Size by Country
  10. 8.3.1 North America Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Animal Blood Plasma Products and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Animal Blood Plasma Products and Derivatives Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Animal Blood Plasma Products and Derivatives Market Size by Type
  2. 9.1.1 Europe Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2032)
  3. 9.1.2 Europe Animal Blood Plasma Products and Derivatives Sales by Type (2021-2032)
  4. 9.1.3 Europe Animal Blood Plasma Products and Derivatives Price by Type (2021-2032)
  5. 9.2 Europe Animal Blood Plasma Products and Derivatives Market Size by Application
  6. 9.2.1 Europe Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2032)
  7. 9.2.2 Europe Animal Blood Plasma Products and Derivatives Sales by Application (2021-2032)
  8. 9.2.3 Europe Animal Blood Plasma Products and Derivatives Price by Application (2021-2032)
  9. 9.3 Europe Animal Blood Plasma Products and Derivatives Market Size by Country
  10. 9.3.1 Europe Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Animal Blood Plasma Products and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Animal Blood Plasma Products and Derivatives Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Animal Blood Plasma Products and Derivatives Market Size by Type
  2. 10.1.1 China Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2032)
  3. 10.1.2 China Animal Blood Plasma Products and Derivatives Sales by Type (2021-2032)
  4. 10.1.3 China Animal Blood Plasma Products and Derivatives Price by Type (2021-2032)
  5. 10.2 China Animal Blood Plasma Products and Derivatives Market Size by Application
  6. 10.2.1 China Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2032)
  7. 10.2.2 China Animal Blood Plasma Products and Derivatives Sales by Application (2021-2032)
  8. 10.2.3 China Animal Blood Plasma Products and Derivatives Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Animal Blood Plasma Products and Derivatives Market Size by Type
  2. 11.1.1 Asia Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2032)
  3. 11.1.2 Asia Animal Blood Plasma Products and Derivatives Sales by Type (2021-2032)
  4. 11.1.3 Asia Animal Blood Plasma Products and Derivatives Price by Type (2021-2032)
  5. 11.2 Asia Animal Blood Plasma Products and Derivatives Market Size by Application
  6. 11.2.1 Asia Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2032)
  7. 11.2.2 Asia Animal Blood Plasma Products and Derivatives Sales by Application (2021-2032)
  8. 11.2.3 Asia Animal Blood Plasma Products and Derivatives Price by Application (2021-2032)
  9. 11.3 Asia Animal Blood Plasma Products and Derivatives Market Size by Country
  10. 11.3.1 Asia Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Animal Blood Plasma Products and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Animal Blood Plasma Products and Derivatives Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Animal Blood Plasma Products and Derivatives Market Size by Type
  2. 12.1.1 SAMEA Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Animal Blood Plasma Products and Derivatives Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Animal Blood Plasma Products and Derivatives Price by Type (2021-2032)
  5. 12.2 SAMEA Animal Blood Plasma Products and Derivatives Market Size by Application
  6. 12.2.1 SAMEA Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Animal Blood Plasma Products and Derivatives Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Animal Blood Plasma Products and Derivatives Price by Application (2021-2032)
  9. 12.3 SAMEA Animal Blood Plasma Products and Derivatives Market Size by Country
  10. 12.3.1 SAMEA Animal Blood Plasma Products and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Animal Blood Plasma Products and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Animal Blood Plasma Products and Derivatives Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Animal Blood Plasma Products and Derivatives Value Chain Analysis
  2. 13.1.1 Animal Blood Plasma Products and Derivatives Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Animal Blood Plasma Products and Derivatives Production Mode & Process
  6. 13.2 Animal Blood Plasma Products and Derivatives Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Animal Blood Plasma Products and Derivatives Distributors
  9. 13.2.3 Animal Blood Plasma Products and Derivatives Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst